Targeting Specific Brain Networks to Treat Specific Symptoms in Depression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-12

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Repetitive transcranial magnetic stimulation (rTMS) is a way of non-invasively stimulating specific brain networks and is an established treatment for Major Depressive Disorder (MDD). This proposal will reveal network mechanisms of the therapeutic effects of rTMS by investigating how stimulating each network specifically changes network connectivity and behavior. This will be done in a highly individualized manner in depressed and healthy patients, leading to more effective and more individualized treatments for depression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Individualized Functional Connectivity Targeting in aiTBS for Depression

NCT05680727

Depressive Disorder, Major Depression Mood Disorders +2 more

ACTIVE_NOT_RECRUITING PHASE2

Neuronavigation Guided iTBS With Personalized Target for Depression

NCT05577481

Depression

ENROLLING_BY_INVITATION PHASE2

Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes

NCT03289923

Major Depressive Disorder

COMPLETED NA

Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression

NCT05422417

Treatment-resistant Depression Major Depressive Disorder

RECRUITING NA

Neural Mechanisms of Intermittent Theta Burst Stimulation in the Core Depression Network

NCT05224206

Major Depressive Disorder

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Network models are increasingly invoked to characterize the neurobiological underpinnings of mental illnesses. Dysfunction within specific circuits promotes the formation of specific symptoms. This suggests an opportunity to treat specific symptoms by modulating specific circuits. Repetitive transcranial magnetic stimulation (rTMS) is capable of circuit-specific neuromodulation. It is also an established treatment for Major Depressive Disorder (MDD). Clinical experience suggests that rTMS treats different symptom constructs by stimulating different circuits. However, there remains a critical lack of mechanistic evidence to support putative network mechanisms of rTMS, limiting its ability to treat patients with more personalized and optimized approaches. This mechanistic proposal will first use resting-state functional connectivity (FC) MRI and customized analytic pipelines to characterize functional network topography in healthy and depressed individuals at high resolution.This data will be used to derive rTMS targets functionally situated in discrete prefrontal networks (e.g., control, default, salience, limbic/reward). Next, patients will take part in a within-subject design in which they undergo rTMS to each target on separate days. Each target will be stimulated four times on a given day, and after each stimulation changes will be measured with: (1) REST-BOLD MRI (to assess FC changes), (2) TASK-BOLD MRI (to assess changes in BOLD activation on paradigms validated to test RDoC constructs), (3) state-based questionnaires or (4) neuropsychological tests. This work will facilitate individualized neuromodulation approaches based on network topography. This will pollinate large-scale clinical trials assessing the effects of differential circuit modulation. It will also illuminate circuit-construct relationships across neuropsychiatric disorders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depressive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Within-subject crossover study

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Participants will receive active or sham stimulation and will be blinded as to the stimulation type.

Intervention Type DEVICE

iTBS is a form of non-invasive brain stimulation used to treat depression. It works on the principles of electromagnetic induction.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intermittent Theta Burst Stimulation (iTBS)

iTBS is a form of non-invasive brain stimulation used to treat depression. It works on the principles of electromagnetic induction.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Repetitive Transcranial Magnetic Stimulation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 years of age
* Capacity to provide informed consent form to participate in the study

* 18-65 years of age
* Capacity to provide informed consent form to participate in the study
* Currently in a major depressive episode. Comorbid anxiety disorders and personality disorders will be allowed provided that MDD is the primary diagnosis.

Exclusion Criteria

* Meeting criteria, in the past or currently, for bipolar affective disorder, hypomania or mania.
* Meeting criteria, in the past or currently, for a primary psychotic disorder (e.g., schizophrenia).
* Neurological conditions with known structural brain lesions, e.g., intracranial masses, multiple sclerosis.
* Any personal history of seizures or a family history of epilepsy in a first-degree relative.
* Metal in the body that is ferromagnetic or metallic injury to the eyes.
* Implanted pacemakers, medication pumps, vagal stimulators, deep brain stimulators, or ventriculoperitoneal shunts, etc.
* Substance abuse or dependence that is current and active within the last six months, as indicated by self-report (e.g., heroin, cocaine, methamphetamines).
* Inability to meet the safety criteria for MRI scanning for any other reason.
* Severe or unstable medical illness.
* Currently pregnant, as assessed with urine pregnancy test in women of childbearing age.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes